Date of management change: April 15, 2013
Dorval, QC-based Clementia Pharmaceuticals Appointed Clarissa Desjardins as Chief Executing Officer
Clementia is a biopharmaceutical company that is focused on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease. Our lead program is palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
Press Release
Short ProfileName: Clarissa Desjardins
Title: Chief Executing Officer
Company: Clementia Pharmaceuticals
Industry: Biotechnology
Current Contact InfoEmail: ***********@clementiapharma.com
Phone:.***.***.*60*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Bloodworth Allison, Reifel Douglas, Tobin Tracy, Vaslow Jill, Orloff Andrew, Albini Edward, Purri Sandhydeep, Collar Anathea, Oyewole Lola, Vanduyn Michael, Pavlakovich Christine
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
